减肥药,第一次全线触底

《财经》杂志
Aug 13

炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会!   股价集体下跌背后,是投资者对GLP-1市场持续增长的不确定   文|《财经》记者凌馨   编辑|王小   在2025年上半年戴上全球“药王”王冠后,减肥和降糖药GLP-1的全球两家顶尖生产商,都经历了一轮大跌。   诺和诺德股价跌至2019年水平,礼来的股价也在一天内跌去14.14%,回到一年前。唯一有长效GLP-1...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10